Killian discussed this a bit at the AGM. Big Pharma like to wait and are more likely to engage when there is proof of concept. Good phase II results or a product in phase III will get their interest
Ann: Cynata Annual General Meeting Presentation, page-25
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
27.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $50.13M | |||
| Open | High | Low | Value | Volume |
| 27.5¢ | 27.8¢ | 27.0¢ | $9.193K | 33.99K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 32056 | 26.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 27.5¢ | 2271 | 1 |
View Market Depth
| Last trade - 10.48am 08/10/2024 (20 minute delay) ? |
| CYP (ASX) Chart |